John Williamson
Impact in
-
- Antibiotic Use and Resistance
- Parasitology top 2%
- Parasitic Infections and Diagnostics
Papers in
-
- COVID-19 Clinical Research Studies 10
- SARS-CoV-2 and COVID-19 Research 4
- Clostridium difficile and Clostridium perfringens research 3
-
- Antibiotic Use and Resistance 11
- Co-authors
- Christopher A. Ohl (12 shared papers)James Wheeler Johnson (13 shared papers)James R. Beardsley (14 shared papers)William L. Salzer (1 shared paper)D. Matthew Shoemaker (1 shared paper)Vera P. Luther (11 shared papers)Paul Samuel Pegram (2 shared papers)Elizabeth L. Palavecino (9 shared papers)
- Journals
- Annals of Pharmacotherapy (5 papers)JAMA (5 papers)JAMA Network Open (3 papers)Open Forum Infectious Diseases (3 papers)Clinical Infectious Diseases (3 papers)
- Partner nations
- United StatesBangladeshFrance
In The Last Decade
John Williamson
58 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 92
- Applied Microbiology and Biotechnology 211
- Parasitology 288
- Infectious Diseases 495
- Pharmacology 297
- Critical Care and Intensive Care Medicine 70
Countries citing papers authored by John Williamson
This map shows the geographic impact of John Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Williamson more than expected).
Fields of papers citing papers by John Williamson
This network shows the impact of papers produced by John Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Williamson. The network helps show where John Williamson may publish in the future.
Co-authors
The 25 scholars most cited alongside John Williamson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 239 | |
| 2 | 2007 | 207 | |
| 3 | 2006 | 114 | |
| 4 | 2007 | 108 | |
| 5 | 2005 | 88 | |
| 6 | 2005 | 87 | |
| 7 | 2015 | 82 | |
| 8 | 2022 | 70 | |
| 9 | 2022 | 59 | |
| 10 | 2012 | 57 | |
| 11 | 2023 | 53 | |
| 12 | 2000 | 51 | |
| 13 | 2009 | 48 | |
| 14 | 2011 | 48 | |
| 15 | 2022 | 48 | |
| 16 | 2023 | 48 | |
| 17 | 2023 | 44 | |
| 18 | 2006 | 43 | |
| 19 | 2013 | 39 | |
| 20 | 2016 | 38 |
About John Williamson
John Williamson is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology and Epidemiology, having authored 61 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (11 papers), COVID-19 Clinical Research Studies (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Sepsis Diagnosis and Treatment (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (211 citations), Parasitology (288 citations), Infectious Diseases (495 citations), Pharmacology (297 citations) and Critical Care and Intensive Care Medicine (70 citations). John Williamson has collaborated with scholars based in United States, Bangladesh and France. Frequent co-authors include Christopher A. Ohl, James Wheeler Johnson, James R. Beardsley, William L. Salzer, D. Matthew Shoemaker, Vera P. Luther, Paul Samuel Pegram, Elizabeth L. Palavecino, Caryn Bern and Heather L. Cox. Their work appears in journals such as Annals of Pharmacotherapy, JAMA, JAMA Network Open, Open Forum Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.